Holdings of PROFUND VP BIOTECHNOLOGY
ProFunds · Original filing · Compare with another fund · Report an error
- Net assets
- 48.8M $ including 47.4M $ in equities, 97.1 %
- Positions
- 149 in 6 countries
- Top ten
- 13.0 % of net assets
- Filed on
- Jun 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Apogee Therapeutics Inc | 5,323 | 706.5K $ | 1.45 % |
| 2 | MODERNA INC | 9,574 | 670.5K $ | 1.37 % |
| 3 | TWIST BIOSCIENCE CORP | 6,497 | 668.4K $ | 1.37 % |
| 4 | ORUKA THERAPEUTICS INC | 6,876 | 654.4K $ | 1.34 % |
| 5 | KYMERA THERAPEUTICS INC | 5,628 | 645.4K $ | 1.32 % |
| 6 | Viking Therapeutics Inc | 15,866 | 618.9K $ | 1.27 % |
| 7 | Praxis Precision Medicines Inc | 1,830 | 612.7K $ | 1.26 % |
| 8 | Erasca Inc | 32,931 | 603.3K $ | 1.24 % |
| 9 | REVOLUTION MEDICINES INC | 3,054 | 572K $ | 1.17 % |
| 10 | Rhythm Pharmaceuticals Inc | 5,137 | 570.4K $ | 1.17 % |
| 11 | CG ONCOLOGY INC | 8,017 | 569.6K $ | 1.17 % |
| 12 | SELLAS Life Sciences Group Inc | 38,263 | 564.8K $ | 1.16 % |
| 13 | VAXCYTE INC | 9,694 | 563.5K $ | 1.15 % |
| 14 | Dianthus Therapeutics Inc | 5,761 | 561.6K $ | 1.15 % |
| 15 | CYTOKINETICS INC | 6,565 | 559.3K $ | 1.15 % |
| 16 | NATERA INC | 2,034 | 552.1K $ | 1.13 % |
| 17 | Scholar Rock Holding Corp | 9,986 | 549.2K $ | 1.13 % |
| 18 | Roivant Sciences Ltd | 15,498 | 548.5K $ | 1.12 % |
| 19 | MIRUM PHARMACEUTICALS INC | 4,684 | 548.4K $ | 1.12 % |
| 20 | COGENT BIOSCIENCES INC | 14,031 | 543K $ | 1.11 % |
| 21 | Ultragenyx Pharmaceutical Inc | 16,214 | 541.4K $ | 1.11 % |
| 22 | TRAVERE THERAPEUTICS INC | 9,420 | 535.2K $ | 1.10 % |
| 23 | Alkermes PLC | 10,043 | 526.2K $ | 1.08 % |
| 24 | Krystal Biotech Inc | 1,409 | 523.7K $ | 1.07 % |
| 25 | Celcuity Inc | 4,990 | 522.1K $ | 1.07 % |
| 26 | Relay Therapeutics Inc | 27,879 | 521.6K $ | 1.07 % |
| 27 | Spyre Therapeutics Inc | 5,864 | 520.6K $ | 1.07 % |
| 28 | TG THERAPEUTICS INC | 9,448 | 519.1K $ | 1.06 % |
| 29 | Beam Therapeutics Inc | 14,930 | 512.4K $ | 1.05 % |
| 30 | Protagonist Therapeutics Inc | 4,163 | 510.3K $ | 1.05 % |
| 31 | Insmed Inc | 4,786 | 510.3K $ | 1.05 % |
| 32 | Arrowhead Pharmaceuticals Inc | 6,225 | 507.4K $ | 1.04 % |
| 33 | VERA THERAPEUTICS INC | 11,718 | 502.8K $ | 1.03 % |
| 34 | Vertex Pharmaceuticals Inc | 1,011 | 502.2K $ | 1.03 % |
| 35 | Madrigal Pharmaceuticals Inc | 934 | 501.5K $ | 1.03 % |
| 36 | AbbVie Inc | 1,957 | 492.5K $ | 1.01 % |
| 37 | Biogen Inc | 2,267 | 489.8K $ | 1.00 % |
| 38 | PTC Therapeutics Inc | 6,003 | 489.7K $ | 1.00 % |
| 39 | Halozyme Therapeutics Inc | 6,245 | 488.8K $ | 1.00 % |
| 40 | uniQure NV | 10,597 | 488.1K $ | 1.00 % |
| 41 | Bridgebio Pharma Inc | 6,532 | 486.5K $ | 1.00 % |
| 42 | CRISPR Therapeutics AG | 8,906 | 485.7K $ | 1.00 % |
| 43 | IMMUNITYBIO INC | 55,254 | 483.7K $ | 0.99 % |
| 44 | Summit Therapeutics Inc | 32,957 | 480.2K $ | 0.98 % |
| 45 | IONIS PHARMACEUTICALS INC | 6,005 | 476.1K $ | 0.98 % |
| 46 | Incyte Corp | 4,178 | 473.6K $ | 0.97 % |
| 47 | Amgen Inc | 1,304 | 472.2K $ | 0.97 % |
| 48 | Neurocrine Biosciences Inc | 2,737 | 461.3K $ | 0.94 % |
| 49 | Gilead Sciences Inc | 3,624 | 457.9K $ | 0.94 % |
| 50 | Regeneron Pharmaceuticals Inc | 732 | 456.4K $ | 0.94 % |
| 51 | Exelixis Inc | 8,374 | 455.6K $ | 0.93 % |
| 52 | ALNYLAM PHARMACEUTICALS INC | 1,512 | 455.2K $ | 0.93 % |
| 53 | BioMarin Pharmaceutical Inc | 7,839 | 448.5K $ | 0.92 % |
| 54 | ACADIA Pharmaceuticals Inc | 17,586 | 444.9K $ | 0.91 % |
| 55 | Nuvalent Inc | 3,569 | 440.8K $ | 0.90 % |
| 56 | IMMUNOVANT INC | 11,393 | 439K $ | 0.90 % |
| 57 | United Therapeutics Corp | 809 | 438.3K $ | 0.90 % |
| 58 | Intellia Therapeutics Inc | 25,453 | 430.7K $ | 0.88 % |
| 59 | GRAIL Inc | 6,303 | 430.3K $ | 0.88 % |
| 60 | BioCryst Pharmaceuticals Inc | 42,367 | 423.7K $ | 0.87 % |
| 61 | Catalyst Pharmaceuticals Inc | 13,200 | 414.9K $ | 0.85 % |
| 62 | DYNE THERAPEUTICS INC | 18,359 | 407.8K $ | 0.84 % |
| 63 | Tango Therapeutics Inc | 12,783 | 399.6K $ | 0.82 % |
| 64 | Denali Therapeutics Inc | 15,367 | 395.2K $ | 0.81 % |
| 65 | Veracyte Inc | 6,617 | 388.6K $ | 0.80 % |
| 66 | Ideaya Biosciences Inc | 10,232 | 381.3K $ | 0.78 % |
| 67 | Recursion Pharmaceuticals Inc | 97,873 | 359.2K $ | 0.74 % |
| 68 | SAREPTA THERAPEUTICS INC | 19,723 | 354.4K $ | 0.73 % |
| 69 | ARCUS BIOSCIENCES INC | 11,440 | 352.7K $ | 0.72 % |
| 70 | Syndax Pharmaceuticals Inc | 15,597 | 341K $ | 0.70 % |
| 71 | Arcutis Biotherapeutics Inc | 12,884 | 337.8K $ | 0.69 % |
| 72 | Mineralys Therapeutics Inc | 12,471 | 336.5K $ | 0.69 % |
| 73 | Celldex Therapeutics Inc | 8,957 | 333.3K $ | 0.68 % |
| 74 | Agios Pharmaceuticals Inc | 8,865 | 329K $ | 0.67 % |
| 75 | VIRIDIAN THERAPEUTICS INC | 17,346 | 318.6K $ | 0.65 % |
| 76 | Novavax Inc | 33,288 | 313.6K $ | 0.64 % |
| 77 | Disc Medicine Inc | 4,238 | 310K $ | 0.64 % |
| 78 | ADMA Biologics Inc | 34,452 | 288.4K $ | 0.59 % |
| 79 | Immunome Inc | 13,266 | 281.1K $ | 0.58 % |
| 80 | PALVELLA THERAPEUTICS INC | 1,812 | 276.9K $ | 0.57 % |
| 81 | Iovance Biotherapeutics Inc | 64,260 | 267.3K $ | 0.55 % |
| 82 | Absci Corp | 22,928 | 265.7K $ | 0.54 % |
| 83 | Nurix Therapeutics Inc | 10,904 | 264.5K $ | 0.54 % |
| 84 | Kodiak Sciences Inc | 6,630 | 258.3K $ | 0.53 % |
| 85 | Biohaven Ltd | 16,808 | 250.1K $ | 0.51 % |
| 86 | Vericel Corp | 5,295 | 235.6K $ | 0.48 % |
| 87 | AnaptysBio Inc | 3,487 | 235.4K $ | 0.48 % |
| 88 | Capricor Therapeutics Inc | 9,630 | 231.9K $ | 0.48 % |
| 89 | Stoke Therapeutics Inc | 6,977 | 228.3K $ | 0.47 % |
| 90 | Monte Rosa Therapeutics Inc | 9,372 | 226.8K $ | 0.46 % |
| 91 | Vir Biotechnology Inc | 21,927 | 223.4K $ | 0.46 % |
| 92 | Hyperliquid Strategies Inc | 28,063 | 220.9K $ | 0.45 % |
| 93 | TYRA BIOSCIENCES INC | 6,173 | 197.2K $ | 0.40 % |
| 94 | Corvus Pharmaceuticals Inc | 12,998 | 194.2K $ | 0.40 % |
| 95 | Cullinan Therapeutics Inc | 10,542 | 192K $ | 0.39 % |
| 96 | Precigen Inc | 31,415 | 179.1K $ | 0.37 % |
| 97 | Inhibrx Biosciences Inc | 1,778 | 168.5K $ | 0.35 % |
| 98 | Taysha Gene Therapies Inc | 24,676 | 168K $ | 0.34 % |
| 99 | Ardelyx Inc | 32,884 | 167.7K $ | 0.34 % |
| 100 | AVALO THERAPEUTICS INC | 8,998 | 166.3K $ | 0.34 % |
Sector breakdown
- Health care 13.6 %
- Unattributed 86.4 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 95.0 %
- Ireland 1.2 %
- Bermuda 1.2 %
- Netherlands 1.0 %
- Switzerland 1.0 %
- British Virgin Islands 0.5 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 143 | 45.1M $ | 95.02 % |
| 2 | Ireland | 2 | 589.3K $ | 1.24 % |
| 3 | Bermuda | 1 | 548.5K $ | 1.16 % |
| 4 | Netherlands | 1 | 488.1K $ | 1.03 % |
| 5 | Switzerland | 1 | 485.7K $ | 1.02 % |
| 6 | British Virgin Islands | 1 | 250.1K $ | 0.53 % |
Cite this page
Titelia. "Holdings of PROFUND VP BIOTECHNOLOGY". https://titelia.com/en/funds/S000003965